MRI-based adrenal gland volume is associated with cardiovascular alterations in individuals without prior cardiovascular disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 06 2024
Historique:
received: 16 02 2024
accepted: 24 06 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 25 6 2024
Statut: epublish

Résumé

Aim of this study was to analyse the associations of cardiovascular health and adrenal gland volume as a rather new imaging biomarker of chronic hypothalamic-pituitary-adrenal (HPA) axis activation. The study population originates from the KORA population-based cross-sectional prospective cohort. 400 participants without known cardiovascular disease underwent a whole-body MRI. Manual segmentation of adrenal glands was performed on VIBE-Dixon gradient-echo sequence. MRI based evaluation of cardiac parameters was achieved semi-automatically. Cardiometabolic risk factors were obtained through standardized interviews and medical examination. Univariate and multivariate associations were derived. Bi-directional causal mediation analysis was performed. 351 participants were eligible for analysis (56 ± 9.1 years, male 58.7%). In multivariate analysis, significant associations were observed between adrenal gland volume and hypertension (outcome hypertension: Odds Ratio = 1.11, 95% CI [1.01, 1.21], p = 0.028), left ventricular remodelling index (LVRI) (outcome LVRI: β = 0.01, 95% CI [0.00, 0.02], p = 0.011), and left ventricular (LV) wall thickness (outcome LV wall thickness: β = 0.06, 95% CI [0.02, 0.09], p = 0.005). In bi-directional causal mediation analysis adrenal gland volume had a borderline significant mediating effect on the association between hypertension and LVRI (p = 0.052) as well as wall thickness (p = 0.054). MRI-based assessment of adrenal gland enlargement is associated with hypertension and LV remodelling. Adrenal gland volume may serve as an indirect cardiovascular imaging biomarker.

Identifiants

pubmed: 38918570
doi: 10.1038/s41598-024-65673-2
pii: 10.1038/s41598-024-65673-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14664

Informations de copyright

© 2024. The Author(s).

Références

Selye, H. Endocrine reactions during stress. Curr. Res. Anesth. Analg. 35(3), 182–193 (1956).
doi: 10.1213/00000539-195605000-00004 pubmed: 13317484
Björntorp, P. & Rosmond, R. Obesity and cortisol. Nutrition 16(10), 924–936 (2000).
doi: 10.1016/S0899-9007(00)00422-6 pubmed: 11054598
Kessing, L. V., Willer, I. S. & Knorr, U. Volume of the adrenal and pituitary glands in depression. Psychoneuroendocrinology 36(1), 19–27 (2011).
doi: 10.1016/j.psyneuen.2010.05.007 pubmed: 20646833
Sapolsky, R. M., Romero, L. M. & Munck, A. U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21(1), 55–89 (2000).
pubmed: 10696570
McEwen, B. S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338(3), 171–179 (1998).
doi: 10.1056/NEJM199801153380307 pubmed: 9428819
WHO. World Health Organization. Global Health Estimates: Deaths by Causes, Age, Sex and Country 2000–2012 (WHO, 2014).
Walker, B. R. Glucocorticoids and cardiovascular disease. Eur. J. Endocrinol. 157(5), 545–559 (2007).
doi: 10.1530/EJE-07-0455 pubmed: 17984234
Iob, E. & Steptoe, A. Cardiovascular disease and hair cortisol: A novel biomarker of chronic stress. Curr. Cardiol. Rep. 21(10), 116 (2019).
doi: 10.1007/s11886-019-1208-7 pubmed: 31471749 pmcid: 6717172
Pereg, D. et al. Hair cortisol and the risk for acute myocardial infarction in adult men. Stress 14(1), 73–81 (2011).
doi: 10.3109/10253890.2010.511352 pubmed: 20812871
Report, W. H. Reducing Risks, Promoting Healthy Life 2002 (World Health Organization, 2002).
Whitworth, J. A., Mangos, G. J. & Kelly, J. J. Cushing, cortisol, and cardiovascular disease. Hypertension 36(5), 912–916 (2000).
doi: 10.1161/01.HYP.36.5.912 pubmed: 11082166
Burford, N. G., Webster, N. A. & Cruz-Topete, D. Hypothalamic–pituitary–adrenal axis modulation of glucocorticoids in the cardiovascular system. Int. J. Mol. Sci. 18(10), 2150 (2017).
doi: 10.3390/ijms18102150 pubmed: 29035323 pmcid: 5666832
Bamberg, F. et al. Subclinical disease burden as assessed by whole-body MRI in subjects with prediabetes, subjects with diabetes, and normal control subjects from the general population: The KORA-MRI study. Diabetes 66(1), 158–169 (2017).
doi: 10.2337/db16-0630 pubmed: 27999110
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B. & Castelli, W. P. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann. Intern. Med. 110(2), 101–107 (1989).
doi: 10.7326/0003-4819-110-2-101 pubmed: 2521199
De Castro, S. et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: A real-time three-dimensional echocardiographic study. Heart 93(2), 205–209 (2007).
doi: 10.1136/hrt.2006.093997 pubmed: 16914482
Cohn, J. N., Ferrari, R. & Sharpe, N. Cardiac remodeling–concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35(3), 569–582 (2000).
doi: 10.1016/S0735-1097(99)00630-0 pubmed: 10716457
Askani, E. et al. Association of MRI-based adrenal gland volume and impaired glucose metabolism in a population-based cohort study. Diabetes Metab. Res. Rev. 38, e3528 (2022).
doi: 10.1002/dmrr.3528 pubmed: 35303389
Imaki, T., Naruse, M. & Takano, K. Adrenocortical hyperplasia associated with ACTH-dependent Cushing’s syndrome: Comparison of the size of adrenal glands with clinical and endocrinological data. Endocr. J. 51(1), 89–95 (2004).
doi: 10.1507/endocrj.51.89 pubmed: 15004414
Bertagna, X. Effects of chronic ACTH excess on human adrenal cortex. Front. Endocrinol. (Lausanne) 8, 43 (2017).
doi: 10.3389/fendo.2017.00043 pubmed: 28337175
Gill, G. N. ACTH regulation of the adrenal cortex. Pharmacol. Ther. B 2(2), 313–338 (1976).
pubmed: 183221
Turpeinen, U. & Hämäläinen, E. Determination of cortisol in serum, saliva and urine. Best Pract. Res. Clin. Endocrinol. Metab. 27(6), 795–801 (2013).
doi: 10.1016/j.beem.2013.10.008 pubmed: 24275191
Stalder, T. & Kirschbaum, C. Analysis of cortisol in hair–state of the art and future directions. Brain Behav. Immun. 26(7), 1019–1029 (2012).
doi: 10.1016/j.bbi.2012.02.002 pubmed: 22366690
Stalder, T. et al. Stress-related and basic determinants of hair cortisol in humans: A meta-analysis. Psychoneuroendocrinology 77, 261–274 (2017).
doi: 10.1016/j.psyneuen.2016.12.017 pubmed: 28135674
Pfeffer, M. A. & Braunwald, E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81(4), 1161–1172 (1990).
doi: 10.1161/01.CIR.81.4.1161 pubmed: 2138525
Ganau, A. et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J. Am. Coll. Cardiol. 19(7), 1550–1558 (1992).
doi: 10.1016/0735-1097(92)90617-V pubmed: 1534335
Storz, C. et al. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population. Eur. Heart J. Cardiovasc. Imaging 19(6), 701–708 (2018).
doi: 10.1093/ehjci/jex190 pubmed: 28950340
Aneja, A., Tang, W. H., Bansilal, S., Garcia, M. J. & Farkouh, M. E. Diabetic cardiomyopathy: Insights into pathogenesis, diagnostic challenges, and therapeutic options. Am. J. Med. 121(9), 748–757 (2008).
doi: 10.1016/j.amjmed.2008.03.046 pubmed: 18724960
Bornstein, A. B., Rao, S. S. & Marwaha, K. Left Ventricular Hypertrophy. StatPearls (StatPearls Publishing, 2022).
Holle, R., Happich, M., Lowel, H., Wichmann, H. E., MKS Group. KORA—A research platform for population based health research. Gesundheitswesen 67(Suppl 1), S19–S25 (2005).
doi: 10.1055/s-2005-858235 pubmed: 16032513
Demirkiran, A. et al. Cardiovascular magnetic resonance techniques for tissue characterization after acute myocardial injury. Eur. Heart J. Cardiovasc. Imaging 20(7), 723–734 (2019).
doi: 10.1093/ehjci/jez094 pubmed: 31131401
Teo, K. S. et al. Cardiac MRI assessment of left and right ventricular parameters in healthy Australian normal volunteers. Heart Lung Circ. 17(4), 313–317 (2008).
doi: 10.1016/j.hlc.2007.11.136 pubmed: 18314390
WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation 13–28 (World Health Organization, 2006).
Purnell, J. Q. Definitions, Classification, and Epidemiology of Obesity. In Endotext (eds Feingold, K. R. et al. et al.) (MDText.com, Inc, Paris, 2000).
Ruf, E., Baumert, J., Meisinger, C., Döring, A. & Ladwig, K. H. Are psychosocial stressors associated with the relationship of alcohol consumption and all-cause mortality?. BMC Public Health 14, 312 (2014).
doi: 10.1186/1471-2458-14-312 pubmed: 24708657 pmcid: 3986452
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation Statistical Computing, 2020).

Auteurs

Esther Askani (E)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Susanne Rospleszcz (S)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Epidemiology, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
German Center for Cardiovascular Disease Research (DZHK E.V.), Munich, Germany.

Roberto Lorbeer (R)

Department of Radiology, Ludwig-Maximilans-University Hospital, Munich, Germany.

Charlotte Wintergerst (C)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Katharina Müller-Peltzer (K)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Johanna Nattenmüller (J)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dunja Hasic (D)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ricarda von Krüchten (R)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Elias Kellner (E)

Medical Physics, Department of Radiology, Medical Centre - University of Freiburg, Freiburg, Germany.

Marco Reisert (M)

Medical Physics, Department of Radiology, Medical Centre - University of Freiburg, Freiburg, Germany.

Wolfgang Rathmann (W)

Institute of Biometrics and Epidemiology, German Diabetes Center, Duesseldorf, Germany.
German Center for Diabetes Research (DZD), Partner Site Neuherberg, Neuherberg, Germany.

Annette Peters (A)

Department of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany.
Institute of Epidemiology, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany.
German Center for Cardiovascular Disease Research (DZHK E.V.), Munich, Germany.
German Center for Diabetes Research (DZD), Partner Site Neuherberg, Neuherberg, Germany.

Christopher L Schlett (CL)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Fabian Bamberg (F)

Department of Diagnostic and Interventional Radiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Corinna Storz (C)

Department of Neuroradiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Breisacher Str. 64, 79106, Freiburg, Germany. corinna.storz@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH